Long-term treatment of social phobia with clonazepam.

Conference Paper

Twenty-six socially phobic outpatients were treated with clonazepam for the relief of symptoms. At evaluation, which took place after an average of 11.3 months of continuous treatment, 22 (84.6%) patients showed good improvement and 4 (14.4%) showed no improvement or were not recovered. The dose declined over time, from a peak mean of 2.1 mg/day to a mean of 0.94 mg/day at follow-up. Side effects are described, along with individual case descriptions that illustrate important aspects of the use of benzodiazepines for the treatment of social phobia.

Full Text

Duke Authors

Cited Authors

  • Davidson, JR; Ford, SM; Smith, RD; Potts, NL

Published Date

  • November 1991

Published In

Volume / Issue

  • 52 Suppl /

Start / End Page

  • 16 - 20

PubMed ID

  • 1757453

International Standard Serial Number (ISSN)

  • 0160-6689

Conference Location

  • United States